In breast cancer, biomarkers such as ER (estrogen receptor), PR (progesterone receptor), and HER2 (human epidermal growth factor receptor 2) are utilized for the identification of intrinsic subtypes [10,11,12,13]. The gene discussed is ERBB2; the disease is breast carcinoma.